Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate—Free Radical Scavenger and Growth Factor Inhibition

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/bmri/volume-2017/1909258/figures/1909258.fig.003a.svgz" name="1909258.fig.003a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Overall UAER changes from baseline between CaD and control treatment groups</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/bmri/volume-2017/1909258/figures/1909258.fig.003b.svgz" name="1909258.fig.003b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>UAER changes from baseline between CaD monotherapy and control treatment groups</td></tr><tr class="fig-image" id="c"><td><object data="https://static.hindawi.com/articles/bmri/volume-2017/1909258/figures/1909258.fig.003c.svgz" name="1909258.fig.003c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>UAER changes from baseline between CaD in combination with ACE-inhibitor/ARB treatment group compared to ACE-inhibitor/ARB monotherapy groups</td></tr></table>

BioMed Research International

fig3

Figure 3

Figure 3: Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate—Free Radical Scavenger and Growth Factor Inhibition 

Figure 3 | Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate—Free Radical Scavenger and Growth Factor Inhibition 